Conference abstractPublished 3 Nov 2014
Irreversible Electroporation (IRE) treatments of 130 patients with prostate cancers in various stages over three years: A safety study
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Introduction & Objectives: The field of prostate cancer in diagnosis and treatment has seen a lot of restructuring in the past years. A higher awareness and steady improvements in medical and biological technologies (PSA screening, MRI, PET scan, Histoscanning, genetic tests.) facilitate the diagnosis of prostate cancer and subsequent treatments. With this technological advancement, men with prostate cancers including low-risk prostate cancers are being more and more treated, which has been controversial and the subject of much debate. These concerns have influenced the treatment approach and brought more interest in less radical approaches like active surveillance or focal therapy, the latter causing an arms race of different ablation technologies. Two new procedures bring drastic changes in the ablation physics and hence very different properties: Photodynamic therapy (PDT) and Irreversible electroporation (IRE). IRE is based on ultra-short and rather strong electrical fields disrupting the cellular homeostasis by creating irreversible micro- and nano-pores in cell membranes, which cause apoptosis and subsequent cell death. The apoptotic cell death produces scaring and pain sensation to a very low level. Tissue heating is so negligible and the margin of the treatment field is extremely sharp. Being based on electrical fields, the effect zone is rather easy to plan and minimize side effects outside the IRE zone. Although IRE is much less tissue specific than PDT, it still comes with the promise of a certain tissue selectivity. Volume geometry and size is dynamically adjustable over a range of a few ten mm³ up to several hundred ccm³ using a concept of 2-6 sequentially triggered electrodes. We present our experience with 139 tissue ablations using Irreversible Electroporation (IRE) on 130 patients since May 2011. Objective is to assess the safety of IRE for treatment of prostate cancers in various stages. Material & Methods:For 130 patients rejecting all other treatment options, IRE (Nanoknife, Angiodynamics) was preformed to treat their various stages of adenocarcinomas (T1aN0MO ? T4NXM1c). 25 patients had history of recurrences after other treatments (5 TUTPs, 8 IRE, 4 radiations, 3 HIFUs, 3 prostatectomies alone and 2 prostatectomies and radiations). Multiparametric MRI was performed in 100% of the cases prior and 12 ? 24 hours after the IRE. MRI planed 3d-Mapping Biopsies of the prostate were obtained to determine the exact location in 47% of the cases. Whole gland ablations (n=23) or partial gland ablation (n=80) were performed. Mean percentage of ablated tissue was 64%. Treatment field also included urethra, neurovascular bundle, bladder, rectum, urethral sphincter, seminal vesicles and small bowel (n=93, 82, 24, 2, 12, 27, 1, respectively). Clinical and/or MRIs follow-ups were obtained at 3, 7, 12, 18, 26, 36 month intervals. Retrospective analysis was performed on 103 patients, who completed at least first 3-month-followup. Results:Only 2 of 103 patients (1.9%) needed post-procedural hospitalization (one catheter-induced infection and one rectourethral fistula): no surgical interventions were needed. Average recuperation and Foley catheterization time was 1-2 days. No pain medications above WHO level 1 required. 12 patients (11%) reported a temporary (n=10, 3 years) reduction in potency. 3 patients (3%) reported transient dysuria. 14 patients (13%) reported transient urinary retention. 12 patients (11%) developed transient incontinence (n=8) or urgency (n=4) after procedure. 5 patients (4%) reported dysejaculation. 3 patients (3%) reported post-procedural infection (cystitis, epididymo-orchitis, or other infection). Conclusion:IRE offers a new effective therapeutic option for treatment of prostate adenocarcinomas in various stages and improved safety profiles, favorable to other conventional treatments. Further long-term prospective studies are needed for oncological & functional outcomes.
Subjects
General & Internal MedicineAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalTranslational Medicine
- SubjectGeneral & Internal Medicine
- BylineArticles whose byline prints “Ducksoo Kim”
- BylineArticles whose byline prints “Roger T Tomihama”
- BylineArticles whose byline prints “Enric Günther”
- BylineArticles whose byline prints “Michael Stehling”
